These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15057917)
1. Electric foot shock stress-induced exacerbation of alpha-galactosylceramide-triggered apoptosis in mouse liver. Chida Y; Sudo N; Sonoda J; Sogawa H; Kubo C Hepatology; 2004 Apr; 39(4):1131-40. PubMed ID: 15057917 [TBL] [Abstract][Full Text] [Related]
2. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115 [TBL] [Abstract][Full Text] [Related]
3. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. Biburger M; Tiegs G J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810 [TBL] [Abstract][Full Text] [Related]
5. Social disruption stress exacerbates alpha-galactosylceramide-induced hepatitis in mice. Sonoda J; Chida Y; Sudo N; Kubo C Neuroimmunomodulation; 2005; 12(6):375-9. PubMed ID: 16557038 [TBL] [Abstract][Full Text] [Related]
6. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. Biburger M; Tiegs G J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134 [TBL] [Abstract][Full Text] [Related]
8. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide. Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice. Inui T; Nakashima H; Habu Y; Nakagawa R; Fukasawa M; Kinoshita M; Shinomiya N; Seki S J Hepatol; 2005 Oct; 43(4):670-8. PubMed ID: 15922476 [TBL] [Abstract][Full Text] [Related]
10. Electric foot-shock stress drives TNF-alpha production in the liver of IL-6-deficient mice. Chida Y; Sudo N; Motomura Y; Kubo C Neuroimmunomodulation; 2004; 11(6):419-24. PubMed ID: 15467358 [TBL] [Abstract][Full Text] [Related]
11. A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine. Fujii H; Seki S; Kobayashi S; Kitada T; Kawakita N; Adachi K; Tsutsui H; Nakanishi K; Fujiwara H; Ikarashi Y; Taniguchi M; Kronenberg M; Ikemoto M; Nakajima Y; Arakawa T; Kaneda K Virchows Arch; 2005 Jun; 446(6):663-73. PubMed ID: 15906084 [TBL] [Abstract][Full Text] [Related]
12. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761 [TBL] [Abstract][Full Text] [Related]
13. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor. Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359 [TBL] [Abstract][Full Text] [Related]
14. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3. Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013 [TBL] [Abstract][Full Text] [Related]
15. Activation of CD11b+ Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice. Nakashima H; Ogawa Y; Shono S; Kinoshita M; Nakashima M; Sato A; Ikarashi M; Seki S PLoS One; 2013; 8(1):e49339. PubMed ID: 23372642 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390 [TBL] [Abstract][Full Text] [Related]
17. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Nakashima H; Inui T; Habu Y; Kinoshita M; Nagao S; Kawaguchi A; Miura S; Shinomiya N; Yagita H; Seki S Gastroenterology; 2006 Nov; 131(5):1573-83. PubMed ID: 17064698 [TBL] [Abstract][Full Text] [Related]
18. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity. Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119 [TBL] [Abstract][Full Text] [Related]
19. The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor. Hiramoto T; Chida Y; Sonoda J; Yoshihara K; Sudo N; Kubo C Gastroenterology; 2008 Jun; 134(7):2122-31. PubMed ID: 18439427 [TBL] [Abstract][Full Text] [Related]
20. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model. Ito H; Hoshi M; Ohtaki H; Taguchi A; Ando K; Ishikawa T; Osawa Y; Hara A; Moriwaki H; Saito K; Seishima M J Immunol; 2010 Oct; 185(8):4554-60. PubMed ID: 20844202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]